The major toxicities were myelosuppression, febrile neutropenia, alopecia, digestive tract reactions and fatigue.
不良反应主要有骨髓抑制、粒细胞减少性发热、脱发、消化道反应和乏力。
OBJECTIVE To assess the clinical effectiveness of antibiotic combined therapy for febrile neutropenia as an empirical treatment.
目的评价经验性联合抗生素治疗粒细胞缺乏伴发热感染的临床效果。
After the third treatment cycle, bevacizumab was associated with significantly more toxic events, particularly febrile neutropenia and pulmonary hemorrhage.
在第三个治疗周期后，贝伐单抗与显著增多的毒性事件有关系，特别是发热引起的粒细胞减少和肺出血。
Toxicity profiles were not significantly different between regimens for nausea, vomiting, diarrhea, febrile neutropenia, dehydration, or 60-day all-cause mortality.
毒性事件如恶心、呕吐、腹泻、发热性中性粒细胞减少、脱水或者60天各种原因所致的死亡率在两个治疗方案之间并无明显差别。
As the current evidence shows, pemetrexed has similar efficacy to docetaxel for advanced NSCLC patients, but it has fewer side effects of neutropenia, febrile neutropenia and alopecia.
结论当前证据显示，培美曲塞与多西紫杉醇治疗晚期NSCLC的疗效相当，但可减少中性粒细胞减少、粒细胞性发热和脱发等不良反应。
As the current evidence shows, pemetrexed has similar efficacy to docetaxel for advanced NSCLC patients, but it has fewer side effects of neutropenia, febrile neutropenia and alopecia.
结论当前证据显示，培美曲塞与多西紫杉醇治疗晚期NSCLC的疗效相当，但可减少中性粒细胞减少、粒细胞性发热和脱发等不良反应。
应用推荐